Riskpilot← Back to searchSign inGet full accessApofemme Scandinavia AB
ABActiveOrg 5592835721Essinge Brogata 8Retail sale of cosmetic and toilet articles · NACE 4775Est. 20200 employees
Revenue 2025
SEK 261K
+3738% vs 2024
EBITDA margin
72.5%
+805% vs 2024
Equity ratio
80.9%
Financial strength
Net profit 2025
SEK 162K
+603% vs 2024
| Revenue | SEK 261K | +3738% |
| EBITDA | SEK 189K | +805% |
| Net profit | SEK 162K | +603% |
| Total assets | SEK 217K | +626% |
| Equity | SEK 175K | +1167% |
| Employees | 0 | — |
Legal name
Apofemme Scandinavia AB
Org number
5592835721
Legal form
Aktiebolag
NACE code
4775 · Retail sale of cosmetic and toilet articles
Founded
17 november 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Detaljhandel på internet och i butik med hygien- och skönhetsprodukter samt bedriva konsultverksamhet inom IT.
Address
Essinge Brogata 8
Email
maritarickman@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 41 | 21 | 10 | 7 | 261 |
| Staff expenses | — | — | — | −0 | −0 |
| EBITDA | −22 | −37 | −20 | −27 | 189 |
| Depreciation & amort. | −6 | −5 | −5 | −5 | −4 |
| EBIT | −28 | −42 | −25 | −32 | 185 |
| Net financials | — | 0 | 0 | −0 | 0 |
| Profit before tax | −28 | −42 | −25 | −32 | 171 |
| Tax | −0 | — | — | — | −9 |
| Net profit | −28 | −42 | −25 | −32 | 162 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 74 | 35 | 34 | 30 | 217 |
| Equity | 27 | 20 | 15 | 14 | 175 |
| Long-term debt | 36 | — | — | — | — |
| Short-term debt | 12 | 15 | 18 | 16 | 27 |
| Total debt | 48 | 15 | 18 | 16 | 27 |
EBITDA margin
72.5%
This company
15.8%
Market median
+359% vs market
20212025
Equity ratio
80.9%
This company
38.2%
Market median
+112% vs market
20212025
Return on equity
92.1%
This company
18.4%
Market median
+401% vs market
20212025
Net profit margin
61.8%
This company
8.1%
Market median
+663% vs market
20212025
Asset turnover
1.20×
This company
1.12×
Market median
+7% vs market
20212025
Debt / equity
0.24×
This company
0.62×
Market median
+61% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-11-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2024 | |
| Board of Directors | 2024 | |
| Former (3) | ||
| Deputy Board Member | 2024 – 2024 | |
| Board of Directors | 2022 – 2024 | |
| Deputy Board Member | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Apofemme Scandinavia AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jessica Niluka Bjuhr | Deputy Board Member | 0 companies |
| Jonnie Tapani Hiltula | Board of Directors | 0 companies |
| Juha Henrik Hiltula | Deputy Board Member | 0 companies |
| Mikael Amin Aon Dadoun | Deputy Board Member | 0 companies |
| Marita Linnea Rickman | Board of Directors | 0 companies |